ArticleArchives of dermatological research2025
Long non-coding RNA CRNDE promotes the progress of hypertrophic scar via regulating the proliferation and migration of hypertrophic scar fibroblasts through targeting microRNA-29a-3p.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertrophic scar (HS) represents an excessive fibrotic response during the healing of skin injuries, constituting a common and intricate pathological process that is tightly regulated. This study aimed to explore the clinical significance and potential mechanisms of long non-coding RNA CRNDE in the development of HS. This study encompassed 71 HS patients, and the expression levels of lncRNA CRNDE were assessed via RT-qPCR. Concurrently, the concentrations of collagen I A1 and collagen III A1 were quantified using the Enzyme-linked immunosorbent assay (ELISA) technique, while the cellular activities of hypertrophic scar fibroblasts (HSFs) were evaluated through CCK-8 assays, Transwell migration assays, and flow cytometry. Furthermore, a dual-luciferase reporter gene assay was conducted to confirm the target interaction between CRNDE and microRNA -29a-3p. LncRNA CRNDE was markedly upregulated in HS tissues. Silencing lncRNA CRNDE led to a reduction in collagen I A1 and collagen III A1 levels in HSFs, inhibited cell proliferation and migration, and simultaneously promoted cell apoptosis. Moreover, miR-29a-3p expression was downregulated in HS tissues and exhibited a negative correlation with lncRNA CRNDE expression. The effects of lncRNA CRNDE knockdown on collagen I A1/ III A1 levels, cell proliferation, migration, and apoptosis could be partially mitigated by a miR-29a-3p inhibitor. LncRNA CRNDE influenced the biological behaviors of HS through its interaction with miR-29a-3p.
Indexed as
Identifiers
39976754What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.